• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

SPR Therapeutics

NANS 2020: Neuromodulation news you need to know

January 24, 2020 By Nancy Crotti

Neuromodulation devices from companies including Medtronic (NYSE:MDT), Abbott (NYSE:ABT) and SPR Therapeutics are showing promise treating pain. That’s one of the initial takeaways from study results that medical device companies in the neuromodulation space are touting this weekend at NANS 2020 in Las Vegas. NANS is a joint conference of Congress of Neurological Surgeons and the […]

Filed Under: Featured, Neuromodulation/Neurostimulation, Pain Management, Research & Development Tagged With: Abbott, Medtronic, NANS 2020, SPR Therapeutics

SPR Therapeutics announces 1000th placement of nerve stimulation device

December 5, 2019 By Sean Whooley

SPR Therapeutics announced the 1000th commercial placement of its Sprint peripheral nerve stimulation (PNS) system for treating pain. Dr. Henry Vucetic of University Hospitals Case Medical Center (Cleveland) performed the 1000th procedure, treating a patient with shoulder pain due to osteoarthritis. The Sprint PNS system is the only percutaneous PNS device cleared by the FDA […]

Filed Under: Neuromodulation/Neurostimulation, Pain Management Tagged With: SPR Therapeutics

DeviceTalks Q&A: Talking targeted pain management with CEO Maria Bennett

October 23, 2019 By Sarah Faulkner

At DeviceTalks Minnesota 2019, SPR Therapeutics founder, president & CEO Maria Bennett spoke with DeviceTalks program manager Sarah Faulkner about the company’s FDA-cleared peripheral nerve stimulation system for pain management. Want to see these interviews live? Join us at DeviceTalks West – Dec. 9-10 in Santa Clara, Calif.  Sarah: Could you tell us a little […]

Filed Under: DeviceTalks Q&A, Featured, Neuromodulation/Neurostimulation, Pain Management, Regulatory/Compliance Tagged With: DeviceTalks Minnesota, SPR Therapeutics

3M names CEO Roman as board chair | Personnel Moves – February 7, 2019

February 7, 2019 By Fink Densford

3M (NYSE:MMM) said yesterday that its board of directors nominated CEO Mike Roman as its new chairperson, with current exec chair Inge Thulin announcing their intention to retire. The move is slated to take effect following the St. Paul, Minn.-based company’s annual meeting of shareholders on May 14. “Under Inge’s leadership, 3M evolved into a more […]

Filed Under: Business/Financial News, Featured, Wall Street Beat Tagged With: 3m, AdvaMed, Amazon, Biospace Med, Boston Scientific, Digirad Corp., excelmedical, Medtronic, Misonix, Myomo Inc, NxThera Inc., Presbia, Repro-Med Systems Inc., SPR Therapeutics, venturemed

Pain-management firm SPR Therapeutics seeks to raise $20m

January 31, 2019 By Nancy Crotti

SPR Therapeutics has raised $8 million of a $20 million Series C round of funding that began Jan. 19, according to an SEC filing. The Cleveland-based company’s Sprint peripheral nerve stimulation (PNS) system is FDA-cleared for both chronic and acute pain, including post-operative and post-traumatic pain. The product was launched in November 2018 with indications […]

Filed Under: Bioelectronic Medicine, Business/Financial News, Funding Roundup, Neuromodulation/Neurostimulation, News Well, Pain Management Tagged With: SPR Therapeutics

ReShape Lifesciences CEO Gladney to resign | Personnel Moves – January 29, 2019

January 29, 2019 By Fink Densford

ReShape Lifesciences (NSDQ:RSLS) said yesterday that its prez & CEO Dan Gladney will resign from his positions with the company, effective March 31. Gladney will remain with the company as board chair, San Clemente, Calif.-based ReShape Lifesciences said. The company’s board of directors said they will immediately begin to look for a replacement, according to an […]

Filed Under: Business/Financial News, Featured Tagged With: Adherium Limited, AliveCor, AxoGen, Biocoat, Cardinal Health, Cirtec Medical, Functional Neuromodulation, georgiabio, iCad Inc., Ra Medical, ReShape Lifesciences, SPR Therapeutics, vasculardynamics

SPR Therapeutics touts first CRPS treatment with Sprint PNS

November 15, 2018 By Fink Densford

SPR Therapeutics said today that it launched its FDA-cleared Sprint Endura single-lead peripheral nerve stimulation system intended for treating complex regional pain syndrome. Complex regional pain syndrome is a chronic pain condition affecting the limbs that can be caused by trauma, injury or surgery. The Cleveland-based company said that the device was used in its first […]

Filed Under: Blog Tagged With: SPR Therapeutics

SPR Therapeutics wins $10m from the DoD

October 3, 2018 By Fink Densford

SPR Therapeutics said yesterday it received $10 million from two new grants and a contract from the US Dept. of Defense, all to support its percutaneous peripheral nerve stimulation therapy intended as a non-opioid pain relief therapy for both acute and chronic pain. The new awards bring the total number of grants and contracts the Cleveland, […]

Filed Under: Business/Financial News, Clinical Trials, Pain Management Tagged With: SPR Therapeutics

SPR Therapeutics’ new PNS system wins FDA nod

August 16, 2018 By Nancy Crotti

The FDA has approved SPR Therapeutics’ (Cleveland) Sprint endura (single lead) and extensa (dual lead) peripheral nerve stimulation (PNS) systems. The minimally invasive Sprint system is the only FDA-approved percutaneous PNS system that is indicated for up to 60 days in the back and/or extremities for both chronic and acute pain and is the industry’s only dual lead […]

Filed Under: Food & Drug Administration (FDA), Neuromodulation/Neurostimulation, Pain Management Tagged With: FDA, SPR Therapeutics

SPR Therapeutics raises $25m to support Sprint PNS system

September 14, 2017 By Fink Densford

SPR Therapeutics said today it raised $25 million in a Series C round of financing to support commercialization and further research of its Sprint peripheral nerve stimulation system. The round was led by a “prominent family office” and Frontcourt Ventures, the Cleveland-based company said. As part of the funding, the company said it appointed former West […]

Filed Under: Business/Financial News, Pain Management Tagged With: SPR Therapeutics

SPR Therapeutics wins FDA nod for peripheral nerve stim pain relief device

July 29, 2016 By Fink Densford

Pain management company SPR Therapeutics yesterday said it won FDA 510(k) clearance for its Sprint peripheral nerve stimulation system designed to provide chronic pain relief. The Cleveland, Ohio-based company touted the Sprint system as the 1st reversible and minimally-invasive PNS to win FDA clearance for treating chronic and acute pain, including post-operative and post-traumatic pain. […]

Filed Under: 510(k), Food & Drug Administration (FDA), Neuromodulation/Neurostimulation, Pain Management, Regulatory/Compliance Tagged With: SPR Therapeutics

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS